🇺🇸 FDA
Patent

US 10881735

Phase change nanodroplet conjugates for targeted delivery

granted A61KA61K41/0028A61K41/0033

Quick answer

US patent 10881735 (Phase change nanodroplet conjugates for targeted delivery) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K41/0028, A61K41/0033, A61K47/6925, A61K9/107